Device Sports Med Knee

Acufex Director

Payments companies reported to CMS as associated with Acufex Director. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$103Kassociated payments (2023-2025)
116clinicians with associated payments
1company reporting

By year

2023 $29K
2024 $43K
2025 $31K

Payments reported as associated with Acufex Director, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Sports Medicine (Orthopaedic Surgery) $92K
Orthopaedic Surgery $6,761
Adult Reconstructive Orthopaedic Surgery $2,098
Physician Assistant $607
Nurse Practitioner $474
Medical $254

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Acufex Director

These are the largest totals companies reported as associated with Acufex Director. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Leon Paulos Pearland, TX Sports Medicine (Orthopaedic Surgery) $74,752.10
Nikhil Verma Chicago, IL Sports Medicine (Orthopaedic Surgery) $13,922.68
Scott Faucett Washington, DC Orthopaedic Surgery $1,584.90
Frank Johannes Plate Pittsburgh, PA Adult Reconstructive Orthopaedic Surgery $984.00
Justin Newman Vail, CO Orthopaedic Surgery $864.47
Chancellor Gray Gainesville, FL Adult Reconstructive Orthopaedic Surgery $784.18
Bradford Waddell Dallas, TX Orthopaedic Surgery $747.77
Jorge Chahla Munster, IN Sports Medicine (Orthopaedic Surgery) $700.00
Sabrina Strickland New York City, NY Sports Medicine (Orthopaedic Surgery) $650.00
Ronak Patel Hinsdale, IL Sports Medicine (Orthopaedic Surgery) $600.00

Prescribed Acufex Director?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.